Trials / Unknown
UnknownNCT01935193
Aspirin Resistance Reversibility in Diabetic Patients
Impact of Different Pharmacological Formulations on Aspirin Resistance Reversibility in Diabetics Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Azienda Ospedaliera San Giovanni Battista · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is assessing the prevalence of aspirin resistance in a cohort of diabetic patients. Those found resistant has been undergone pharmacological tests using different drug formulations to investigate the reversibility of aspirin resistance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lysine acetylsalicylate |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-08-01
- First posted
- 2013-09-05
- Last updated
- 2013-09-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01935193. Inclusion in this directory is not an endorsement.